President & CEO of Cara Therapeutics, Inc. (NASDAQ:CARA), Chalmers Derek T, sells 6,078 shares worth $92,993
According to Cara Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 06:12 PM, company President & CEO, Chalmers Derek T disclosed selling 6,078 shares at a cost of $15.30. At the time of this transaction (Dec 30), this trade was worth $92,993 in total. As of Dec 30, Chalmers Derek T now owns 936,593 shares in total worth about $14,404,800.34.
For the last few recent trades made by Cara Therapeutics, Inc. (NASDAQ:CARA) President & CEO, Chalmers Derek T, we have the following information:
- SEC Form 4 filing: Dec 28: Sold 5,000 shares at the rate of $16.00 per share. Total worth of this trade was $80,000. Total number of shares owned as of Dec 28 were 942,671
- SEC Form 4 filing: Dec 16: Sold 5,000 shares at the rate of $14.95 per share. Total worth of this trade was $74,750. Total number of shares owned as of Dec 16 were 928,921
- SEC Form 4 filing: Dec 10: Sold 7,500 shares at the rate of $15.29 per share. Total worth of this trade was $114,675. Total number of shares owned as of Dec 10 were 933,921
Posted by
George Daniels
on Wednesday December 30 2020, 9:52 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
